nsc-290205 and Breast-Neoplasms

nsc-290205 has been researched along with Breast-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for nsc-290205 and Breast-Neoplasms

ArticleYear
Further studies on the anti-neoplastic activity of 3 beta-hydroxy-13 alpha-amino-13,17-seco-5 alpha-androstan-17-oic-13,17-lactam [p-[bis(2-chloroethyl)amino]-phenyl]acetate (NSC 290205).
    Cancer letters, 1984, Volume: 22, Issue:2

    The modified steroidal alkylating agent 3 beta-hydroxy-13 alpha-amino-13,17-seco-5 alpha-androstan-17-oic-13,17-lactam [p-[bis(2-chloroethyl)amino]phenyl]acetate (NSC 290205) is active in treating the LX-1 lung and MX-1 breast xenografts as well as a number of rodent tumors. Of 13 tumors tested, activity has been shown in 10 systems. Two systems have not received adequate testing and negative results were recorded in 1 system.

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Azasteroids; Breast Neoplasms; Cell Line; Colonic Neoplasms; Drug Evaluation, Preclinical; Humans; Leukemia, Experimental; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma; Mice; Neoplasm Transplantation; Neoplasms; Nitrogen Mustard Compounds

1984